-
c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling.
Science. 1994 Oct 21;266(5184):443-8
PMID: 7939685
-
Bone and haematopoietic defects in mice lacking c-fos.
Nature. 1992 Dec 24-31;360(6406):741-5
PMID: 1465144
-
Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses.
Immunity. 1996 Nov;5(5):407-15
PMID: 8934568
-
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Cell. 1997 Apr 18;89(2):309-19
PMID: 9108485
-
TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells.
J Biol Chem. 1997 Oct 3;272(40):25190-4
PMID: 9312132
-
Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2.
Nat Med. 1997 Nov;3(11):1285-9
PMID: 9359707
-
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Nature. 1997 Nov 13;390(6656):175-9
PMID: 9367155
-
Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice.
Immunity. 1997 Nov;7(5):715-25
PMID: 9390694
-
Requirement for NF-kappaB in osteoclast and B-cell development.
Genes Dev. 1997 Dec 15;11(24):3482-96
PMID: 9407039
-
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.
Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3597-602
PMID: 9520411
-
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Cell. 1998 Apr 17;93(2):165-76
PMID: 9568710
-
osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Genes Dev. 1998 May 1;12(9):1260-8
PMID: 9573043
-
Functional analysis of the PTH/PTHrP network of ligands and receptors.
Recent Prog Horm Res. 1998;53:283-301; discussion 301-3
PMID: 9769712
-
The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor.
J Biol Chem. 1998 Oct 23;273(43):28355-9
PMID: 9774460
-
The parathyroid hormone/parathyroid hormone-related peptide receptor coordinates endochondral bone development by directly controlling chondrocyte differentiation.
Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13030-5
PMID: 9789035
-
The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily.
J Biol Chem. 1998 Dec 18;273(51):34120-7
PMID: 9852070
-
RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis.
Biochem Biophys Res Commun. 1998 Dec 18;253(2):395-400
PMID: 9878548
-
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis.
Nature. 1999 Jan 28;397(6717):315-23
PMID: 9950424
-
Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif.
J Biol Chem. 1999 Mar 19;274(12):7724-31
PMID: 10075662
-
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.
Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3540-5
PMID: 10097072
-
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling.
Genes Dev. 1999 Apr 15;13(8):1015-24
PMID: 10215628
-
Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation.
Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9803-8
PMID: 10449775
-
A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3.
J Bone Miner Res. 1999 Sep;14(9):1478-85
PMID: 10469275
-
RANK is essential for osteoclast and lymph node development.
Genes Dev. 1999 Sep 15;13(18):2412-24
PMID: 10500098
-
The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.
J Bone Miner Res. 2000 Jan;15(1):2-12
PMID: 10646108
-
Role of osteoblasts in hormonal control of bone resorption--a hypothesis.
Calcif Tissue Int. 1981;33(4):349-51
PMID: 6271355
-
Effects of interleukin-1 on bone turnover in normal mice.
Endocrinology. 1989 Sep;125(3):1142-50
PMID: 2788075
-
Modulation of osteoclast differentiation.
Endocr Rev. 1992 Feb;13(1):66-80
PMID: 1555533
-
Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells.
Nat Med. 1996 Aug;2(8):876-82
PMID: 8705856